Ligand Pharma (LGND) Tops Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 316.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $316.13 | 52 Week High | $139.79 | |||
| Open | $316.13 | 52 Week Low | $82.07 | |||
| Day High | $316.13 | P/E | 735.19 | |||
| Day Low | $316.13 | EPS | $0.43 | |||
| Volume | 1 | |||||
